Table 3.
Comparison of miRNAs expression level between acute and post-acute COVID-19 groups with Healthy Control group (Control group as a reference group).
| Cellular miRNAs | Acute COVID-19 vs Control group | Post-Acute COVID-19 vs Control group | Acute COVID-19 vs Post-Acute-COVID-19 |
|---|---|---|---|
| miR-29a-3p | F: 3.5 | F: 5.3 | F: 3.4 |
| T: 6.3 | T: 12.8 | T: 3.7 | |
| P: <0.0001 | P: <0.0001 | P: 0.001 | |
| miR-155-5p | F: 3.7 | F: 4.4 | F: 1.3 |
| T: 5.06 | T: 10 | T: 1.14 | |
| P: <0.0001 | P: <0.0001 | P: ns | |
| miR-146a-3p | F: 2.8 | F: 4.4 | F: 2.9 |
| T: 4.38 | T: 8.9 | T: 3.5 | |
| P: 0.0001 | P: <0.0001 | P: 0.002 | |
| Let-7b-3p | F: 1.7 | F: 3.1 | F:2.7 |
| T: 3.2 | T: 6.3 | T: 3.1 | |
| P: 0.002 | P: <0.0001 | P: 0.006 |
F: Fold change (log2), T: t-value, P is adjusted P-value based on the marginally adjusted p values by the Benjamini-Hochberg-FDR correction at α = 0.05.